Although dysregulated HDAC activity may lead to hypertension and data suggest that in angiotensin II– or obesity-induced hypertension HDACi may lower pressure (54–56), we also found in our meta-analysis that HDACi led to a significant risk of a change in pressure. The gene discussed is HDAC9; the disease is obesity due to melanocortin 4 receptor deficiency.